Predictable Failure (and How to Avoid It) for Early-Stage Life Science Companies
Life science founders are technical experts in their fields, but frequently fail to understand the needs of the stakeholders who drive the path to market. This gap sends investors running, and all but ensures immediate or eventual company failure.
Once aware of this gap in knowledge, many are:
- Overwhelmed by a complex stakeholder ecosystem;
- Slow to take action to close their knowledge gap;
- Unfamiliar with the resources available to do so;
- Unaware of the โunknown unknownsโ and unlikely systematically conduct a comprehensive investigation
- Unable to assimilate collected infoย into a strategic plan.
Don’t let that be your story! These problems are preventable if only founders follow a robust, methodical process that allows them to discover to understand the needs and motivations of each stakeholder and develop a plan to close this gap. Doing so significantly de-risks their business model, while providing them with a framework from which to create an evidence-based product development plan.
In this webinar, Dr. Lucia Mokres breaks down the six major stakeholder categories relevant to most life science companies and shares key strategies for closing the knowledge gap between founders and their market success.
